Enveric Biosciences, Inc. Total Revenue

• Enveric Biosciences, Inc. showed a decrease of -7.2% in Total Revenue from 2018 to 2019.
• This data is from Enveric Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2020.
• XBRL data for this metric is available from 2016 to 2019 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2017: $12.34 million | Q2 2017: $12.27 million | Q3 2017: $12.53 million | Q1 2018: $11.06 million | Q2 2018: $11.08 million | Q3 2018: $10.58 million | Q1 2019: $10.69 million | Q2 2019: $11.02 million | Q2 2019: $11.02 million | Q3 2019: $9.15 million | Q3 2019: $9.15 million | Q1 2020: $9.60 million | Q2 2020: $8.25 million | Q3 2020: $8.48 million.
• Over the full 4 years of available data (2016 to 2019), Enveric Biosciences, Inc.'s Total Revenue has grown by 10.4%.
• Historical annual values: Fiscal year 2019: $39.91 million | Fiscal year 2018: $43.00 million | Fiscal year 2017: $48.59 million | Fiscal year 2016: $36.15 million.
• Data sourced from SEC EDGAR public filings as of August 4, 2026.

Last verified: August 4, 2026